Document is current
Any future updates will be listed below
-
Authors
Neumann, Manuela
Van den Broeck, Marleen
Wynants, Sarah
Cheung, Simon
Prudlo, Johannes
Hermann, Andreas
Synofzik, Matthis
Briemberg, Hannah
Hsiung, Ging-Yuek R.
Rademakers, Rosa
Mackenzie, Ian R. A.
-
Funding
Funding for this research was provided by:
National Institutes of Health, USA (UG3 NS103870, UAG063911)
- License Information
-
More Information
Article History
Received: 16 October 2025
Revised: 31 October 2025
Accepted: 19 November 2025
First Online: 28 November 2025
Declarations
:
: Dr. Mackenzie is a member of the Scientific Advisory Board of Eli Lilly and Drs. Rademakers and Mackenzie receive invention royalties from a patent related to progranulin. Dr. Neumann is a member of an expert advisors’ working group of Trace Neuroscience. Dr. Hermann has received personal fees and non-financial support from ITF Pharma and Biogen, unrelated to the submitted work.
